Pharmasimple S.A. Stocks

0Last Updated 23.03.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

€ 2283.29371

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Pharmasimple SA operates a Website for medicines, cosmetics, and food supplements in Belgium and France. It offers beauty and cosmetics products, such as face wash, face care, make-up, hair removal, body care, tanning lotions, and hair treatment products; health products, including feminine hygiene, dental hygiene, alternative medicine, hearing aid, and aromatherapy products; and men care products categories, such as face, body, and hair care, as well as shaving products. The company also provides diet products, sport diet, health supplements, and health food; child care product categories, which include nappies, baby washing, breastfeeding equipment, baby food, and baby care products; and veterinary and pest control products. Pharmasimple SA was founded in 2010 and is based in Houdeng-Goegnies, Belgium.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E. Editor's note: P

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks